14 results
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
incurred and expects to expend significant capital and other resources to ensure ongoing compliance with applicable privacy and data security laws
DEF 14A
PNT
POINT Biopharma Global Inc.
28 Apr 22
Definitive proxy
8:36am
programs and management’s periodic evaluation of the effectiveness of such programs;
reviewing the Company’s data security compliance programs, management’s
424B3
PNT
POINT Biopharma Global Inc.
31 Mar 22
Prospectus supplement
11:42am
to ensure ongoing compliance with applicable privacy and data security laws and to prevent security breaches, including costs related to deploying
POS AM
PNT
POINT Biopharma Global Inc.
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
incurred and expects to expend significant capital and other resources to ensure ongoing compliance with applicable privacy and data security laws
424B3
21qd4i 545
5 Aug 21
Prospectus supplement
4:26pm
424B3
clu5060grmm4g6e4
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
u703b4 dzdkn1hgwnr
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
8terg d1ir
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
91doegr
18 Mar 21
Financial Statements and Exhibits
9:08am
- Prev
- 1
- Next